ADAM9, ADAM metallopeptidase domain 9, 8754

N. diseases: 109; N. variants: 6
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0025202
Disease: melanoma
melanoma
0.050 GeneticVariation disease BEFREE To address this question in vivo in a spontaneous melanoma model, we deleted ADAM-9 in mice carrying the hepatocyte growth factor (Hgf) transgene and knock-in mutation Cdk4<sup>R24C/R24C</sup>, demonstrated to spontaneously develop melanoma. 28553955 2017
CUI: C0025202
Disease: melanoma
melanoma
0.050 Biomarker disease BEFREE Looking for the effectors of these antineoplastic functions, we identified ADAM9 and MMP7, two metalloproteases playing a pivotal role in melanoma progression, as direct targets of miR-126&126*. 23437250 2013
CUI: C0025202
Disease: melanoma
melanoma
0.050 AlteredExpression disease BEFREE ADAM-9 is expressed in human melanoma at the tumor-stroma border where direct or indirect interactions between tumor cells and fibroblasts occur. 21135106 2011
CUI: C0025202
Disease: melanoma
melanoma
0.050 AlteredExpression disease BEFREE Using RNAi this EGFR activation was further shown to depend on the metalloproteases ADAM9 and ADAM17 in SCC-9 cells. cDNA array hybridization and RT-PCR analysis showed overexpression of a Disintegrin and a Metalloproteases (ADAMs) and EGF family proligands in melanoma cell lines. 19003995 2009
CUI: C0025202
Disease: melanoma
melanoma
0.050 AlteredExpression disease LHGDN However, we observed downregulation of ADAM-9 mRNA expression upon culture of melanoma cells within 3-dimensional lattices composed of fibrillar type I collagen, whereas culture within gels consisting of the polysaccharide alginate did not alter transcript levels. 15856464 2005
CUI: C0025202
Disease: melanoma
melanoma
0.050 AlteredExpression disease BEFREE RNA analysis of melanoma cell lines with different invasive abilities showed ADAM-9 expression in varying amounts in all cell lines, independent of their invasive and metastatic capacities. 15856464 2005